Patents
Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526)
01/2009
01/07/2009EP1543032B1 Method for the rational mutagenesis of a/beta t cell receptors and correspondingly mutated mdm2 protein-specific a/beta t-cell receptors
01/07/2009EP1532239B1 Methods and compositions for targeting secretory lysosomes
01/07/2009EP1504030B1 Constitutively translocating cell line
01/07/2009EP1476197B1 Synthesis of lipopolysaccharide-protein conjugate vaccines via the lipid a region following removal of the glycosidic phosphate residue
01/07/2009EP1474434B1 The eaat2 promoter and uses thereof
01/07/2009EP1425297B1 Isolation of neural stem cells using gangliosides and other surface markers
01/07/2009EP1409684B1 Novel surface exposed immunoglobulin d-binding protein from moraxella catarrhalis
01/07/2009EP1409538B1 Process for obtaining growth factor (tgf-beta and igf-1), lactoperoxidase and immunoglobulins preparations from milk products having low mutual cross-contamination
01/07/2009EP1407008B1 Influenza vaccine composition
01/07/2009EP1317559B1 Dna transfection system for the generation of infectious negative strand rna virus
01/07/2009EP1311538B1 Inhibitors of hiv replication and method of treatment of hiv infections
01/07/2009EP1220933B1 Purification of recombinant proteins fused to multiple epitopes
01/07/2009EP1212423B1 Identification of the domain of plasmodium falciparum erythrocyte membrane protein 1 (pfemp1) that mediates adhesion to chondroitin sulfate a
01/07/2009EP1203077B1 TRANSGENIC PLANTS EXPRESSING i PHOTORHABDUS /i TOXIN
01/07/2009EP1200590B1 C-type lectin transmembrane antigen expressed in human prostate cancer and uses thereof
01/07/2009EP1198581B1 Method for reducing the antigenicity of adeno-associated virus structural protein
01/07/2009EP1127065B1 Chlamydia antigen and corresponding dna fragments and uses thereof
01/07/2009EP1124984B1 Host cells expressing recombinant human erythropoietin
01/07/2009EP1115874B1 Alzheimer's disease secretase
01/07/2009EP1103564B1 Cancer antigens based on tumor suppressor gene wt1 product
01/07/2009EP1012293B1 Compounds for immunotherapy and diagnosis of tuberculosis and methods of their use
01/07/2009EP1009725B1 13c,15n,2h labeled proteins for nmr structure determinations and their preparation
01/07/2009EP1003879B1 Antigen constructs useful in the detection and differentiation of antibodies to hiv
01/07/2009EP0980389B1 Antigen
01/07/2009EP0870046B1 Recombinant live vaccine containing feline herpes virus type 1, particularly for treating feline infectious peritonitis
01/07/2009EP0787008B1 Thymosin alpha1 in combination with a natural cytokine mixture for the treatment of a cellular immune deficiency
01/07/2009EP0759985B1 Transgenic arthritic mice
01/07/2009EP0721508B1 Receptor-activated reporter systems
01/07/2009EP0662827B2 Diagnostic methods and pharmaceutical compositions based on notch proteins and nucleic acids
01/07/2009CN101341406A Method for prediction of prognosis of acute coronary syndrome
01/07/2009CN101341169A Fsh mutants
01/07/2009CN101341168A Metastin derivatives and use thereof
01/07/2009CN101340814A Methods to produce desired proteins in plants
01/07/2009CN101338316A Gene BrARGOS for controlling organ sizes of Chinese cabbage and use thereof
01/07/2009CN101338314A Recombined chicken alpha interferon gene and recombinant vector thereof
01/07/2009CN101338313A Resistance gene of microtus fortis to schistosoma japonicum and encoded polypeptide thereof
01/07/2009CN101338281A Recombination preparation of dextran sulfate sodium and applications
01/07/2009CN101337989A Novel glucagon-like peptide-1(GLP-1) analogues and use thereof
01/07/2009CN101337988A New erythrocyte-stimulating factor analogues
01/07/2009CN101337987A Anti-cataract target protein
01/07/2009CN101337986A Artificial recombined hexon protein A, constructing method thereof and use
01/07/2009CN100448994C Isolated nucleic acid molecules which encode T cell inducible factors, or interleukin-21, proteins encoded, and uses thereof
01/07/2009CN100448993C Interferon-like protein zcyto 21
01/07/2009CN100448893C Humanized antibodies that recognize beta amyloid peptide
01/07/2009CN100448892C Antitumour vascular endothelial growth factor receptor VEGF-R antigen and its coding gene and application
01/07/2009CN100448891C Peptides and related molecules that bind to TALL-1
01/07/2009CN100448890C Novel protein and process for producing same
01/07/2009CN100448888C Haemostatically active preparation containing VWF and production thereof
01/06/2009US7473830 Plants and seeds of hybrid corn variety CH056821
01/06/2009US7473828 Inbred maize line PHDWA
01/06/2009US7473820 Flax (Linum usitatissimum L.) seed-specific promoters
01/06/2009US7473819 Transgenic cells comprising nucleotide sequences coding serine/threonine kinase related proteins for use in generating drought, salt, heat, and freeze resistant plants; tissue engineering
01/06/2009US7473772 Chimeric GB virus B (GBV-B)
01/06/2009US7473771 Nucleotide sequences coding recombinant protein for use in prevention and treatment of hyperphosphatemia
01/06/2009US7473770 Indentifying analytes which interfere with the interaction between the cDkk-4 protein and a homologous or heterologous Dkk receptor; useful for treating osteoporosis and other bone loss disorders.
01/06/2009US7473769 Produced from Polypedilum vanderplanki larvae; introduction of these genes into animal cells successfully conferred desiccation resistance to the cells.
01/06/2009US7473765 Cytokine zalpha11 ligand
01/06/2009US7473764 Protein composition obtained from a muscle source
01/06/2009US7473763 Encoded by the full-length coding sequence of the complementary DNA deposited under ATCC accession number PTA-2591; may be fused to a heterologous polypeptide; an epitope tag or an Fc region of an immunoglobulin; diagnosis or treatment of immune related diseases
01/06/2009US7473762 solid phase synthesis; for diagnosis/treatment/prophyaxis; animal models; genetic engineering
01/06/2009US7473761 Therapy for metabolic disorders; polycystic kidney diseasel diarrhea; gastrointestinal disorders
01/06/2009US7473760 Cyclic peptide compositions for treatment of sexual dysfunction
01/06/2009US7473682 Angiogenic peptides and uses thereof
01/06/2009US7473680 Forming a convalent conjugate of a peptide, EPO, removing X2 or a saccharyl subunit thereof from peptide forming a truncated glycan; contacting truncated glycan with glycosyltransferase and modified sugar donor under conditions suitable for glycosyltransferase to transfer a modified sugar moiety
01/06/2009US7473679 Treatments employing neuronal exocytosis-inhibiting peptides
01/06/2009US7473671 Glycopeptide antibiotics, combinatorial libraries of glycopeptide antibiotics and methods of producing same
01/06/2009US7473558 Marker useful for detection and measurement of free radical damage and method
01/06/2009US7473554 Polynucleotides encoding novel Bt toxin receptors from lepidopteran insects
01/06/2009US7473553 Isolated nucleic acid; insecticides
01/06/2009US7473542 Therapeutic bioactive ribonucleases for use in the tissue targeted therapy against tumors; tumor cytotoxic factors; antitumor agents
01/06/2009US7473537 Cloned glucagon-like peptide-2 receptors
01/06/2009US7473536 To increase the titer of avipoxviruses produced from cells after infection of cells with the avipoxvirus, wherein the host range gene is expressed in cells
01/06/2009US7473533 Membrane arrays and methods of manufacture
01/06/2009US7473430 Cancer cell targeting gene delivery method
01/06/2009US7473428 Vaccination of pigs against disease by administering a first recombinant porcine adenovirus vector stably expressing a heterologous nucleotide sequence encoding the antigenic determinant of the disease, preferably Hog Cholera Virus or Pseudorabies virus
01/06/2009US7473421 Comprises nucleotide sequences coding immunoglobulin which binds chemokine receptor 2 for use in the treatment and prevention of restenosis
01/06/2009CA2305341C Stabilization of envelope glycoprotein trimers by disulfide bonds introduced into a gp41 glycoprotein ectodomain
01/06/2009CA2294421C A method for plant protection against insects or nematodes
01/06/2009CA2293575C Controlled release microencapsulated ngf formulation
01/06/2009CA2245584C Recombinant expression of s-layer proteins
01/06/2009CA2215335C Cauliflower floral meristem identity genes and methods of using same
01/06/2009CA2191407C Process for using the yeast adh ii promoter system for the biotechnological production of heterologous proteins in high yields
01/06/2009CA2181590C Peptomers with enhanced immunogenicity
01/06/2009CA2179603C Production of pharmaceutical-grade plasmid dna
01/06/2009CA2158446C Nucleic acid coding for a tumor rejection antigen precursor
01/06/2009CA2154628C Xylanase, microorganisms producing the same, dna molecules, process for preparing said xylanase and uses thereof
01/06/2009CA2149770C Detection of hypoxia
01/06/2009CA2144406C Gene transcription and ionizing radiation: methods and compositions
01/06/2009CA2117490C Purified vacuolating toxin from helicobacter pylori and methods to use same
01/06/2009CA2108147C Heterodimeric receptor libraries using phagemids
01/06/2009CA1341589C Methods and deoxyribonucleic acid for the preparation of tissue factor protein
01/06/2009CA1341588C Human ifn-beta2/i1-6, its purification and use
01/01/2009US20090007300 Controlling heterologus gene expression in plants; obtain plant cells, incubate with expression vector transform, monitor expression of preferential gene
01/01/2009US20090007296 capable of conferring environmental stress tolerance to plants upon over-expression; genetic engineering
01/01/2009US20090007283 Transgenic Rodents Selectively Expressing Human B1 Bradykinin Receptor Protein
01/01/2009US20090007280 Ange gene in atopy
01/01/2009US20090005543 Protein-refolding material
01/01/2009US20090005542 Hydrolysable polymeric FMOC- linker
01/01/2009US20090005541 Gag binding protein
01/01/2009US20090005540 Method For Removing Sialic Acid and Method For Producing Asialoerythropoietin